responders received prophylactic cranial radiation ( 2000 rad/10 fractions ) and non cross resistant chemotherapy via a schedule of alternating cycles of cmv ( cyclophosphamide , methotrexate , vp-16-213 ) and amv ( adriamycin , methotrexate , vp-16-213 ) .
C0280591
amv
C0025677
methotrexate